Bluestar Genomics
Latest round
- Series C
Last raised
- Mar 2019
Total raised
- $69M
Investors
- 2
About Bluestar Genomics
Based in California, US, and founded in 2016, Bluestar Genomics Inc. operates as a biotechnology company that develops next-generation epigenomic approaches to detect deadly cancers, like pancreatic, early when curative therapies are possible. Bluestar Genomics Inc. combines novel epigenomic technology with machine learning to detect early pancreatic cancer from a standard blood draw by analyzing cell-free DNA in plasma, these can be used as new biomarkers that can detect pancreatic cancer before the malignancy. Bluestar Genomics Inc. plans to conduct a large clinical validation study to confirm the assay’s ability to detect pancreatic cancer in patients with new-onset diabetes.
Who invested in Bluestar Genomics
2 investors across 1 round
See all investors in Bluestar Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 20, 2019
Amount
$69M
Investors
Questions about Bluestar Genomics
Who invested in Bluestar Genomics?
Bluestar Genomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bluestar Genomics raised?
Bluestar Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bluestar Genomics last raise money?
Bluestar Genomics's most recent round on record is a Series C, in Mar 2019.
What does Bluestar Genomics do?
Based in California, US, and founded in 2016, Bluestar Genomics Inc.
Where is Bluestar Genomics headquartered?
Bluestar Genomics is headquartered in San Diego, US.
Which VCs invest in companies like Bluestar Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bluestar Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bluestar Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.